Research

My group’s research focuses on the analysis of ‘omics data to understand drug response and improve drug design, for diseases like depression leukemia, and pancreatic cancer. Additionally, I work collaboratively with Dr. Alexandre Erkine to process, analyze and understand high-throughput screeens to elucidate transcriptional regulation mechanisms.

Currently, we are conducting systematic reviews and meta-analyses of publicly available ‘omics data, integrating multiple ‘omics levels to understand why some patients respond better to antidepressants than others. We also continue to develop accessible bioinformatics software, including the NanoTube for easier analysis and visualization of NanoString nCounter data.

Highlighted Projects

A full publication list can be found at Google Scholar.

Research involving Butler Students

  • Gene expression signatures of response to fluoxetine treatment: systematic review and meta-analyses. Cooper DG, Cowden JP, Stanley PA, Karbowski JT, Gaertig VS, Lukan CJ, Vo PM, Worthington AD, Class CA. Manuscript under review. Preprint at bioRxiv: https://doi.org/10.1101/2024.02.19.581045
  • Easy NanoString nCounter data analysis with the NanoTube. Class CA, Lukan CJ, Bristow CA, Do KA. Bioinformatics. 2023; 39(1): btac762. DOI: https://doi.org/10.1093/bioinformatics/btac762.
  • Faster Assessment of Fluoxetine Response Using Transcriptomics Data. Cowden JP, Worthington AD, Caleb Class. Presented at ASHP Midyear (2021).
  • Identifying Early Diagnostic Features of Parkinson’s Disease Using Multi-Omics. Van Ravenswaay L, Retzke K, Class CA. Presented at ASHP Midyear (2021).

Collaborative Research involving Butler Students

Other Collaborative Work